Advenchen Pharmaceuticals, LLC.

Published trials2

Recruiting shown1

Roles1

SourceClinicalTrials.gov

Clinical trials

2 shown

Phase 2 Study for the Patient, Who Has Diagnosed With Small Cell Lung Cancer (SCLC) or Non Small Cell Lung Cancer (NSCLC) or Renal Cell Carcinoma (RCC) and Finished the First Line Stand Treatment , Need More TreatmentNCT05363280 · lead sponsor · 2022-11-01

RECRUITING

A Study of AL58805 in Advanced, Metastatic GYN, STS or Breast CancersNCT07811232 · lead sponsor · 2026-09-01

NOT_YET_RECRUITING

Sponsor roles

lead sponsor2

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.